open access
Vol 27, No 5 (2020)
Editorial
Submitted: 2020-10-05
Accepted: 2020-10-05
Published online: 2020-11-06
Get Citation
Cardiac injury is independently associated with mortality irrespective of comorbidity in hospitalized patients with coronavirus disease 2019
,
open access
Vol 27, No 5 (2020)
Editorial
Submitted: 2020-10-05
Accepted: 2020-10-05
Published online: 2020-11-06
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Cardiac injury is independently associated with mortality irrespective of comorbidity in hospitalized patients with coronavirus disease 2019
Journal
Issue
Article type
Editorial
Pages
472-473
Published online
2020-11-06
Page views
417
Article views/downloads
413
DOI
10.5603/CJ.2020.0150
Pubmed
Bibliographic record
Cardiol J 2020;27(5):472-473.
Authors
Miao Yu
Xiang Cheng
References (12)- Nishiga M, Wang DW, Han Y, et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17(9): 543–558.
- Wei ZY, Geng YJ, Huang Ji, et al. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail. 2020 [Epub ahead of print].
- Guan Wj, Liang Wh, Zhao Yi, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Resp J. 2020; 55(5): 2000547.
- Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020 [Epub ahead of print].
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72(18): 2231–2264.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–1062.
- Shi S, Qin Mu, Shen Bo, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7): 802–810.
- Nie SF, Yu M, Xie T, et al. Cardiac troponin I is an independent predictor for mortality in hospitalized patients with COVID-19. Circulation. 2020; 142(6): 608–610.
- Cao J, Zheng Y, Luo Z, et al. Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics. 2020; 10(21): 9663–9673.
- Chapman AR, Bularga A, Mills NL. High-Sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation. 2020; 141(22): 1733–1735.
- Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236): 1569–1578.
- National Health Commission of the People’s Republic of China. Chinese management guideline for COVID-19 (version 8.0). August 19, 2020. http://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a/files/a449a3e2e2c94d9a856d5faea2ff0f94.pdf (accessed Aug 19, 2020; in Chinese).
